BDRX

Biodexa Pharmaceuticals
BDRX

4 hedge funds and large institutions have $17K invested in Biodexa Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Holders
4
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$9.09K
2
+$4.9K

Top Sellers

1
-$14.6K
2
-$924
3
-$211
4
CIM
Contravisory Investment Management
Massachusetts
-$53
Name Holding Trade Value Shares
Change 		Change in
Stake
GI
1
GAMMA Investing
California
$10.3K
SS
2
SBI Securities
Japan
$4.9K
UBS Group
3
UBS Group
Switzerland
$1.72K
RhumbLine Advisers
4
RhumbLine Advisers
Massachusetts
$59
Morgan Stanley
5
Morgan Stanley
New York
–
CIM
6
Contravisory Investment Management
Massachusetts
–